In this episode of Healthcare Matters, Dr. Robert Popovian and co-host Angela Degrassi discuss why uncertainty surrounding the CDC’s Advisory Committee on Immunization Practices, known as ACIP, matters far beyond Washington, DC.
The conversation explains how ACIP recommendations are connected to the real-world systems that help patients get vaccinated, including pharmacist authority, state scope-of-practice laws, and Medicaid reimbursement. Dr. Popovian explains that adult vaccination is especially vulnerable to disruption because most adults receive vaccines at pharmacies, and in many states, pharmacists’ ability to administer vaccines is tied to ACIP recommendations.
The episode also explores why seasonal vaccines, such as flu and COVID vaccines, are particularly exposed to uncertainty because they require updated authorization and recommendations each year. Robert and Angela discuss what happened when COVID vaccine guidance was delayed, how some states responded with temporary workarounds, and why not every state may be prepared to act quickly if similar uncertainty continues.
The discussion also highlights GHLF’s new integration of Walgreens’ Vaccine Scheduler into GHLF’s vaccine hub, a tool designed to help adult patients better understand and access vaccines at local pharmacies.
The key message: ACIP may sound like an advisory body, but its recommendations can directly affect whether patients can get vaccines, whether pharmacists can provide them, and whether Medicaid will pay for them.
Contact Our Hosts
Dr. Robert Popovian, Chief Science Policy Officer at GHLF: rpopovian@ghlf.org
Angela Degrassi, Senior Manager, Patient-Centered Research Operations & Engagement: adegrassi@ghlf.org
A podcast series produced by Amelia Violet Prouse.
We want to hear what you think. Send your comments, or a video or audio clip of yourself, to podcasts@ghlf.org
Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

S7, Ep 4- COVID Antivirals: Are High-Risk Patients Missing the Window?
11:46

S7, Ep 3- 340B: Are Patients Seeing the Savings?
15:03

S7, Ep 2- PBM Reform at an Inflection Point: What Comes Next?
40:22